June 2024

In memoriam: Franz Paul Gruber

It is with deep sadness that we announce the death of our esteemed colleague and friend, Franz Paul Gruber, DVM, PhD, who passed away on April 12, 2023 in Münsterlingen, Switzerland after a prolonged illness.

January 2023

Doerenkamp-Zbinden Award 2022

The 2022 Doerenkamp-Zbinden (DZ) Price was awarded to Andrea Terron on occasion of the ASPIS meeting in Sitges (Spain; 24.-25.11.2022).

December 2022

Head of the Doerenkamp-Zbinden chair in Baltimore receives the EUROTOX Merit Award 2021

Prof. Thomas Hartung, Head of the Doerenkamp-Zbinden-Chair for Evidence-based Toxicology at Johns Hopkins Bloomberg School of Public Health in Baltimore, USA, received the EuroTox Merit award 2021.

December 2022

Doerenkamp-Zbinden Award 2021

The Board of Trustees of the Doerenkamp-Zbinden Foundation for Animalfree Research has chosen the Slovak scientist Dr. Helena Kandárová as the Doerenkamp-Zbinden Prize winner in the year 2021.

November 2022

Call for nominations for Doerenkamp-Zbinden Prize

Nominations for the Doerenkamp-Zbinden Prize 2021 are now open.

October 2020

The Doerenkamp-Zbinden Foundation Chairs for Alternative Methods in Konstanz and Baltimore get the most prestigious award yet

The German Research Council (DFG, German Research Foundation) has awarded the most prestigious Ursula M. Händel Animal Welfare Prize to Marcel Leist and Thomas Hartung, two endowed chairs of the foundation, for their lifework to replace animal testing. The prize of 80,000 Euro will support the work these pioneers of alternatives to animal testing.

April 2014

Thank you, dear Alan

In November 2014 we celebrate the 75th birthday of Alan Goldberg, an iconic figure in the field of alternative methods. Coincidentally, one of the most beloved films of all time, The Wizard of Oz, shares this anniversary.

February 2011

Doerenkamp-Zbinden Chair India: Obituary Hildegard Doerenkamp

History has seen innumerable animal lovers but none like Ms. Hildegard Doerenkamp, the Co-founder of Doerenkamp-Zbinden Foundation, who passed away on Feb 21, 2011.

November 2008

Press Release from Utrecht University

The health risks for people who are exposed to toxic substances are now mainly based on data from animal testing. Thanks to the advancement of biological expertise combined with the use of computer models, those risks can be assessed more and more accurately without having to use animals as a model fo

June 2008

Mahatma Gandhi-Doerenkamp Center founded in India

Between the Bharathidasan University in Tiruchirappalli/Tamil Nadu/India and the Doerenkamp-Zbinden Foundation in Kuesnacht ZH/Switzerland a Memorandum of Understanding was signed on 15th July 2009.

February 2008

NL/CH: Doerenkamp-Zbinden Chair founded at Utrecht University

On the 13th of February 2008, in the office of the dean of the Faculty of Veterinary Medicine at the University of Utrecht, the faculty director, the director of the Institute for Risk Assessment (IRAS) and the president of the Foundation Board of the Doerenkamp-Zbinden Foundation (Zurich) signed a contract to establish an endowed chair at the University of Utrecht for initially six years, with the intention to extend it to eight years.

June 2003

Doerenkamp-Zbinden Chair for Alternative Methods in Konstanz taken up

On the 17th of July 2003 Professor Kay Brune (University of Erlangen), then president of the Doerenkamp-Zbinden Foundation, and Bernhard Koch, member of the governing council and President of the Thurgau Foundation for Science and Research signed an agreement between the two foundations to establish and finance an „Endowed Chair for in vitro Methods for the Replacement of Animal Experiments” at the University of Konstanz (reported in ALTEX 2/2003, p. 99).

December -1

Our Chair in India: PETA Honour Group’s Educational Workshops, Legislative Victories

Delhi – Courtesy of People for the Ethical Treatment of Animals (PETA) India, a Humane Science Award is on the way to the Mahatma Gandhi-Doerenkamp Centre (MGDC), based in Tiruchirappalli, Tamil Nadu, for Alternatives to Use of Animals in Life Science Education.

December -1

Prestigious Lush Prize for a project co-financed by the DZ Foundation

The "Center for Alternatives to Animal Experiments in Europe" (CAAT-Europe) was honored with the Lush Prize for its "CAAT-Europe Policy Program". This is the highest prize given for lobbying and policy interventions promoting the use of alternatives to animal testing.

December -1

December -1

December -1

Foundation Board approves one-year bridge payment for ReTox-21c project

The Project „Modeling of pathways of developmental neurotoxicity as pilot of a paradigm shift for regulatory safety assessments of chemicals – phase 2” will be financed by the Doerenkamp-Zbinden Foundation for the time period of one year.

December -1

t4 project extension for 2 years

On 23rd of April 2012 the Board of the Doerenkamp-Zbinden Foundation approved a 2-year extension of the t4 project (transatlantic-think-tank-toxicology). The goal of the project is to, following the developments of the toxicology field in the USA (Tox 21c), bring topics such as animal-free toxicology research to be intensively discussed in Europe too.

December -1

December -1

Topping out ceremony in India

On 1 Oktober 2011 the president of the Doerenkamp-Zbinden Foundation, Franz P. Gruber, and the chair holder of the Doerenkamp-Naef-Zbinden chair at the University of Geneva, Pierre Cosson, visited the Mahatma-Gandhi-Doerenkamp-Center at the University of Bharathidasan in Tiruchirappalli/Tamil Nadu, India.

December -1

Doerenkamp-Zbinden Chair Thomas Hartung, Director of CAAT, receives 6 Million $ NIH grant

The Johns Hopkins Center for Alternatives to Animal Testing (CAAT) has received a $6 million grant from the National Institutes of Health (NIH) to pioneer potentially revolutionary new methods for toxicological testing to improve human health and reduce animal testing.

December -1

Hildegard Doerenkamp passed away

It is my sad duty to announce that Hildegard Doerenkamp passed away on February 21st, 2011 in a hospital in the black forest, Germany after a short but severe illness. She died a painless and peaceful death in dignity.

December -1

Obituary Doerenkamp-Zbinden Foundation

After a short, severe illness, Ms Hildegard Doerenkamp, cofounder of the Doerenkamp-Zbinden Foundation, passed away on 21 February 2011 at the age of 90. She had been living by herself in the Black Forest, Germany, no longer wanting to endure living in retirement homes or hotels. She was self-sufficient and had finally regained her independence, which she had valued highly all her life.

December -1

December -1

December -1

December -1

USA: Inauguration of the Doerenkamp-Zbinden Chair at Johns Hopkins University

Cheer for chair – some observations from the inauguration of Thomas Hartung as the Doerenkamp-Zbinden Chair for Evidence-based Toxicology

December -1

CH: A Doerenkamp-Naef-Zbinden Chair in Geneva

The contract to establish a Chair for Alternative Methods at the University of Geneva was concluded with determination and much confidence of success.

December -1

USA: A new Doerenkamp-Zbinden chair in Baltimore

In December 08 the Johns Hopkins University in Baltimore/USA entered a contract with the Doerenkamp-Zbinden Foundation in Kuesnacht ZH/Switzerland that will enable Johns Hopkins University to install a permanent Doerenkamp-Zbinden Chair for evidence based toxicology.

December -1

EU/USA: A transatlantic think tank of toxicology (t4)

The foundation board of the Doerenkamp-Zbinden Foundation (DZF) decided to create a toxicological think tank (working name t4 – Transatlantic Think Tank of Toxicology) with the following aims:

December -1

Projects supported by the Doerenkamp-Zbinden Foundation provide results

The Doerenkamp-Zbinden Foundation has continued to actively support a number of projects in the field of alternatives to animal testing in biomedical sciences. Furthered activities are either projects performed within the frame work of the Foundation’s chairs or have been independently supported as projects with a significant impact on the promotion of alternative methods.